News

Deal Announcements

Novophage Garners a Series A Venture Capital

Wednesday, June 1, 2011 5:58:00 AM PDT | VentureDeal Staff
   Cambridge, Massachusetts  --  Biotechnology company Novophage has landed $5.75 million in its first round of institutional venture capital investment.

Novophage is developing anti-biofilm solution technologies for various industry verticals.

Investors in the round included Flybridge Capital Partners, Founder Collective, The Kraft Group and others.

The company said it would use the financing to continue development of its technology.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1